. Author manuscript; available in PMC: 2011 May 6.

Published in final edited form as: J Urol. 2009 Sep 16;182(5):2265–2272. doi: 10.1016/j.juro.2009.07.030

Table 1.

Baseline comparison

Variable	Placebo	Treatment	p Value
Mean ± SE age	69.0 ± 2.2	69.2 ± 2.5	0.94
No. white/black	11/5	15/2
Mean ± SE wt (kg)	97.39 ± 4.73	90.2 ± 4.01	0.25
Mean ± SE BMI (kg/m²)	30.05 ± 1.44	28.71 ± 1.24	0.48
Mean ± SE PSA (ng/ml)	45.05 ± 39.54	3.9 ± 2.58	0.30
Mean ± SE TSH (mIU/ml)	1.98 ± 0.22	1.81 ± 0.24	0.60
ADT duration (yrs)	1.96 ± 0.64	2.37 ± 0.37	0.70
No. gonadotropin-releasing hormone analogues/orchiectomy	16/0	16/1
No. androgen receptor antagonist	1	3
No. radiation therapy	11	13
No. metastasis history	7	7
Mean ± SE No. system review abnormalities	3.19 ± 0.42	3.41 ± 0.52	0.74